Start with the sticker. Mounjaro cost without insurance lands around $1,399 a month in 2026 — that is the brand-name tirzepatide price TrimRx published in its March 2026 press release. Pay cash for a full year and you are staring at roughly $16,788, before a single doctor visit.
Now the twist most pricing pages bury: Mounjaro is FDA-approved for type 2 diabetes, not weight loss. If you want tirzepatide for weight, you will usually be prescribed Zepbound — the identical molecule with a weight-management label — or offered compounded tirzepatide for $89.50 to $499 a month. Compounded tirzepatide is not FDA-approved. This page prices all three routes, then ranks the five cheaper telehealth alternatives from our research.
Mounjaro Cost Without Insurance in 2026: The Real Numbers
No insurance means no negotiated rate. You pay cash, and across the telehealth platforms we researched, brand tirzepatide sits at the top of the board. TrimRx lists brand-name tirzepatide at $1,399/month — and brand semaglutide at $1,299/month — in its March 2026 press release.
The rest of the brand market backs that number up. OMZO’s own terms list Zepbound vials at $1,399/month and brand Ozempic at $1,299/month. MEDVi’s brand-name path charges a $99 membership plus medication cost, and its January 2026 press release lists Ozempic at $1,999/month. Trinity Meds’ funnel page flags brand Ozempic at $999/month with a limited-supply warning.
Here is the 2026 cash landscape in one table:
| Route to tirzepatide | FDA status | Typical cash price in 2026 |
|---|---|---|
| Brand Mounjaro (diabetes label) | FDA-approved for type 2 diabetes | About $1,399/mo via telehealth, per TrimRx press release |
| Brand Zepbound (weight-loss label) | FDA-approved for chronic weight management | $1,399/mo for vials in OMZO terms; $99 membership + med cost at MEDVi |
| Brand Ozempic (semaglutide, for comparison) | FDA-approved for type 2 diabetes | $999-$1,999/mo across these platforms |
| Compounded tirzepatide | Not FDA-approved | $89.50 first-month promo up to $499/mo refills |
Run the math and the gap is brutal. Twelve months of brand tirzepatide at $1,399 is $16,788. Twelve months of the cheapest compounded plan below is $1,638 — about 90% less. That gap is the entire reason the compounded market exists. It is also why the FDA keeps publishing concerns about unapproved GLP-1 drugs.
Mounjaro or Zepbound: Which One Would You Even Be Buying?
Both drugs are tirzepatide, a weekly GLP-1/GIP injection dosed from 2.5 mg up to 15 mg. Mounjaro carries the type 2 diabetes indication. Zepbound carries the chronic weight-management indication — the FDA approved it in November 2023 for adults with obesity, or overweight plus at least one weight-related condition.
Same molecule, same pen-and-vial economics, different label. A clinician treating diabetes writes Mounjaro. A clinician treating weight writes Zepbound. Chasing Mounjaro specifically as a cash-pay weight-loss patient buys you nothing: the price sits in the same $1,399 neighborhood, and the prescription is harder to justify. We unpack the label question in our GLP-1 for diabetes vs weight loss guide.
What you are paying for is real, to be clear. In the SURMOUNT-1 trial, adults on the highest tirzepatide dose lost an average of up to 20.9% of body weight over 72 weeks, alongside diet and exercise. Individual results vary, and no legitimate seller can guarantee yours.
So the practical question becomes: what do the cheaper routes cost, and what do they cost you in fine print? Below are the five tirzepatide alternatives from our research, ranked by editorial score — our method is documented at how we rank. All five sell compounded tirzepatide, which is not FDA-approved. Every score already accounts for that.
1. bmiMD — $139 Flat Tirzepatide That Undercuts Brand by 90%
Score: 8.2/10 (Very Good). bmiMD is the price leader of this ranking. The NYC telehealth platform, in business since late 2022, sells compounded tirzepatide from $139/month with one policy that matters most during a tirzepatide program: the same price at every dose, per its product pages. Against a $1,399 brand listing, that is roughly a 90% discount.
The intake mechanic is smart, too. Your card is authorized, not charged, until a provider approves you — usually via a same-day telehealth consult. Found ineligible? The hold is released and you pay $0.
Pricing Structure
bmiMD prices by commitment length, and the discount is real but front-loaded:
| Plan | Monthly rate | What you actually pay |
|---|---|---|
| 12-month | $139/mo | $1,638 billed upfront |
| 6-month | $149/mo | $864 billed upfront |
| 3-month | $159/mo | $447 billed upfront |
| First-month promo | $89.50 one time | New members only |
The price bundles the medication, provider visit, unlimited messaging, and refill management, with free shipping on subscription orders. HSA/FSA cards work, and buy-now-pay-later is offered. There is no separate membership fee.
Pros & Cons
Pros: Flat price at every dose, so titration never raises your bill. The $89.50 first month is the lowest entry price we found for tirzepatide anywhere. Published quality-testing claims: potency within plus or minus 10%, USP 797 sterility, and endotoxin testing through FDA- and DEA-registered third-party labs. Trustpilot sits around 4 stars across roughly 800+ reviews, per July 2026 search snapshots.
Cons: The best rate demands $1,638 upfront, and all sales are final once the pharmacy processes your order. A $50 non-refundable cancellation fee applies between intake approval and pharmacy processing. BBB rating is C+, not accredited, with 38 complaints on file. Compounding pharmacy partners are unnamed, and there is no brand-name option at all — bmiMD cannot sell you actual Mounjaro or Zepbound. Its compounded tirzepatide is not FDA-approved.
2. TrimRx — The Source of the $1,399 Number, With a $349 Escape Hatch
Score: 7.8/10 (Good). TrimRx is the only platform in this ranking that publicly lists brand-name tirzepatide — $1,399/month, per its March 2026 press release — right alongside compounded tirzepatide at $349/month. That makes it the cleanest side-by-side of what the FDA-approved product costs versus the compounded workaround.
The San Diego company (operating since June 2024) is cash-pay only, but it charges $0 until a prescription is approved, per third-party review. Everything is bundled: provider visits, a 4-5 week supply, syringes, alcohol pads, a sharps container, and cold-chain shipping.
Pricing Structure
TrimRx’s dedicated tirzepatide pricing page advertises $349/month at all doses, from 2.5 mg to 15 mg. But its own March 2026 press release calls $449/month the standard rate, with $349 as promo pricing. Per third-party pricing reports, a 12-month prepaid plan drops the effective cost to about $283/month — the catch being that prepaid plans reportedly give no refunds for unused months after cancellation.
One more flag from our research: TrimRx’s own blog posts have quoted tirzepatide at $299, $349, and $449 in different articles. Screenshot the exact price at checkout.
Pros & Cons
Pros: Flat pricing across the full dose range, confirmed on a dedicated pricing page — rare in this market. No separate consult, shipping, supply, or platform fees. HSA/FSA accepted. BBB accredited since June 2025. Third-party reviews report a conditional guarantee: a 100% medication refund after three consecutive adherent months without progress.
Cons: Trustpilot is a mediocre 3.3/5 across roughly 727 reviews, sharply polarized, with complaints clustering on multi-month billing surprises and cancellation friction. The BBB profile is currently under review with no letter grade displayed. Pharmacy partners are unnamed. The company is barely two years old. Its compounded tirzepatide is not FDA-approved.
3. MEDVi — $349 to Start, Then Your Dose Sets the Bill
Score: 7.6/10 (Good). MEDVi brings the biggest customer base here: Trustpilot around 4.4/5 across roughly 14,000 reviews and a claimed 100,000+ patients. It is also one of the few sellers offering tirzepatide as both a weekly injection and a daily oral dissolvable tablet.
Here is why it ranks third. MEDVi’s famous flat-refill promise — $299/month that never rises — applies to its semaglutide injection plan. Its tirzepatide pricing is murkier, and murky costs money.
Pricing Structure
Compounded tirzepatide starts at $349 for the first month. MEDVi does not publish refill prices; third-party pricing reports put them at $399-$499/month depending on dose. That top rate is 43% above the start price — the exact dose-tier trap flat-price rivals avoid. One review site also reports billing on a 28-day cycle, roughly 13 charges a year instead of 12.
Want the FDA-approved product instead? MEDVi’s brand-name Wegovy/Zepbound path runs a $99 membership plus medication cost, and its press release lists Ozempic at $1,999/month.
Pros & Cons
Pros: Huge, mostly positive review base. Injection and tablet formats. Provider review typically within 24 hours, free expedited shipping, HSA/FSA accepted. MEDVi names its compounding pharmacies — Triad Rx, RedRock Pharmacy, and Beaker Pharmacy & Compounding — which most competitors refuse to do.
Cons: BBB rating F, with 662 complaints filed and 100 unanswered as of July 2026. Recurring complaints describe auto-renewal charges (often $399) and cancellation difficulty. Tirzepatide refill pricing is unpublished and dose-dependent per third parties. Refunds are generally unavailable once a cycle ships, and coverage is 49 states, not 50. Its compounded drugs are not FDA-approved — MEDVi’s own site says so.
4. OMZO — $349 First Month and a $1,399 Zepbound Listing
Score: 6.9/10 (Fair). OMZO posts competitive promo pricing with no contract: compounded tirzepatide at $349 for the first month per its terms (originally listed at $259), then $399/month refills with no dose-based tiers. Its terms also list brand Zepbound vials at $1,399/month for patients who want the FDA-approved product.
Fulfillment is a bright spot on paper. OMZO says medication ships within 48 business hours of prescription approval, with 3-5 business day delivery — and a full refund if nothing ships within 14 business days.
Pricing Structure
The step-up math: $349 to $399 is a 14% increase after month one, locked flat from there. The monthly price bundles the consult, prescription, medication, shipping, and support, with no membership fee. But OMZO’s own pages disagree with each other — semaglutide is $179 on the funnel and $199 in the terms, and Ozempic appears at $1,299/month in the terms but $1,999/month in the site navigation. Refunds outside medical ineligibility or billing errors are off the table, and requests must be emailed within 28 days.
Pros & Cons
Pros: No contract and cancel-anytime billing. Full refund if a provider declines you, plus the 14-business-day shipping guarantee. Oral GLP-1 tablets from $249 for needle-averse patients. Claims availability in all 50 states.
Cons: Almost no track record — about 7 Trustpilot reviews and no BBB profile. No legal entity name or physical address in its terms. Compounding pharmacies unnamed. Internal price contradictions on two products. Its marketing touts a money-back guarantee its own refund terms contradict. The compounded tirzepatide is not FDA-approved, as OMZO’s footer plainly states.
5. Trinity Meds — A $125 Floor Price You Should Read Twice
Score: 6.8/10 (Fair). Trinity Meds owns the lowest tirzepatide sticker in this ranking: $149/month, falling to $125/month on a 12-month plan, with the same price at every dose. It even names its four dispensing pharmacies — Belmar Pharmacy, Strive Pharmacy, Epiq Scripts, and Casa Pharma Rx — a transparency step most rivals skip.
So why last place? Because nearly everything around the price is a caution flag.
Pricing Structure
The main site lists compounded tirzepatide at $149/month, discounted to $144 (3-month), $130 (6-month), and $125 (12-month). Meanwhile the company’s own go.trinitymeds.com funnel lists the same drug from $259/month — a 74% higher figure the same week, per our research — plus a $100-off first-order promo and brand Ozempic at $999/month with a limited-supply flag. FSA-eligible, buy-now-pay-later offered, free tracked shipping.
The terms bite: programs auto-renew until cancelled, consult fees are non-refundable, and all prescription sales are final.
Pros & Cons
Pros: Cheapest 12-month rate here at $125/month — about 91% below the $1,399 brand listing. Four pharmacies publicly named with phone numbers. No insurance required, all-inclusive price, free shipping.
Cons: Trustpilot 2.1/5 from 119 reviews, 65% one-star, with complaints of charges after cancellation. In June 2026, the FDA issued warning letter MARCS-CMS 728236 to Trinity HealthCare Supply, LLC dba altRx — the same LLC name Trinity Meds uses in its own press materials (the letter concerns the altRx site, not trinitymeds.com). State coverage claims conflict: the FAQ says all 50 states, the formal terms say certain states. First delivery can take 1.5-3 weeks per its funnel. No BBB profile found. Its compounded tirzepatide is not FDA-approved.
Can You Get Mounjaro for Weight Loss Without Diabetes?
Usually, no — and it rarely makes financial sense to try. Prescribers treating weight write Zepbound, because that is the tirzepatide product the FDA approved for chronic weight management. Mounjaro’s label is type 2 diabetes, and off-label prescribing for weight is a hard ask when an on-label twin exists.
The cash math is indifferent anyway. Telehealth listings put brand tirzepatide at $1,399/month whichever label it wears, and none of the five programs above bill insurance — all are cash-pay. Several accept HSA/FSA dollars, which can claw back 20-30% of the effective cost depending on your tax bracket.
If a program advertises Mounjaro by name at a too-good price, slow down. Ask which product will actually ship: brand Mounjaro, brand Zepbound, or a compounded copy that is not FDA-approved. Those are three different purchases at three different risk levels.
Why Is Compounded Tirzepatide So Much Cheaper Than Mounjaro Without Insurance?
Because you are not buying the same regulatory product. Compounded tirzepatide is mixed by compounding pharmacies, not manufactured by Eli Lilly, and the FDA does not review it for safety, effectiveness, or quality before sale. Every platform above discloses this — the phrasing on several sites is that the drugs are produced in FDA-registered facilities but are not FDA-approved.
The discount is the trade. At $139-$449/month, compounded plans run roughly 68% to 90% below the $1,399 brand listing. The FDA’s published concerns about unapproved GLP-1s include dosing errors with compounded versions — a live risk when you are drawing doses from a vial instead of clicking a factory-sealed pen.
If you go compounded anyway, buy transparency. Two of our five name their pharmacies (MEDVi and Trinity Meds). One publishes third-party testing claims — bmiMD says potency is verified within plus or minus 10% by FDA- and DEA-registered labs. Zero of the five publish 503A/503B facility status. Ask.
How Do You Keep the Monthly Bill Flat as Your Dose Climbs?
Tirzepatide is a titration drug. You start at 2.5 mg weekly and step up over months toward 15 mg — our Zepbound dosage schedule guide maps the standard climb. Dose-tiered pricing turns that medical schedule into a built-in price hike.
The numbers make the case. At MEDVi, third-party pricing reports put tirzepatide refills at $399-$499/month depending on dose — dose creep alone can add $1,200 a year. Flat-price programs (bmiMD, TrimRx, Trinity Meds) advertise one rate from first injection to max dose, so a $139 plan stays $139.
Before you enroll anywhere, get three answers in writing: the refill price after any promo month, whether that price changes by dose, and the billing cycle — one review site reports MEDVi bills every 28 days, which means about 13 charges a year, an invisible 8% surcharge.
What Should You Check Before Paying Cash for Tirzepatide?
Read the exit before the entrance. bmiMD charges a $50 cancellation fee in the window between intake approval and pharmacy processing, and makes all sales final after that. OMZO accepts refund requests only by email within 28 days, and only for ineligibility or billing errors. Trinity Meds auto-renews until you cancel, with consult fees non-refundable and all prescription sales final.
Then check the complaint file, not the homepage stars. MEDVi pairs a 4.4/5 Trustpilot with an F from the BBB and 662 complaints. Trinity Meds sits at 2.1/5 with 65% one-star reviews. TrimRx’s 3.3/5 splits between delighted and furious, mostly over prepaid billing. Where the record is thin — OMZO’s 7 reviews — price the uncertainty in.
Finally, mind the upfront cash. The cheapest rates in this market are prepaid: $1,638 at once for bmiMD’s $139 rate, with unused months typically non-refundable across the industry. And if you are already on semaglutide and eyeing tirzepatide for the bigger trial numbers, read our guide to switching GLP-1 medications before you buy a 12-month commitment to either drug. The cheapest plan is the one you finish — not the one with the smallest first month.